A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

KINON, Bruce J ; LU ZHANG ; MILLEN, Brian A ; OSUNTOKUN, Olawale O ; WILLIAMS, Judy E ; KOLLACK-WALKER, Sara ; JACKSON, Kimberley ; KRYZHANOVSKAYA, Ludmila ; JARKOVA, Natalia

Journal of clinical psychopharmacology, 2011-06, Vol.31 (3), p.349-355 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível